AstraZeneca said, “If there is an unexplained illness in the middle of a trial, then the trial is stopped.”
London| London-based pharma company AstraZeneca, which is developing the Corona vaccine in collaboration with Oxford University, has halted clinical trials. This decision was taken after a volunteer involved in the trial developed serious illness. The company informed about halting of trials on Tuesday. However, it described it as routine action. It said that the severity of the disease in the patient is not yet known.
AstraZeneca says, “If there is an unexplained illness in the middle of a trial, then the trial is stopped. It sometimes happens in big trials, but we must review it. We are doing this work, so that the timeline of the trial does not have much impact. ”
9 companies have trials in third phase
AstraZeneca started the registration of 30,000 volunteers for the third phase clinical trial from 31 August. AstraZeneca is one of 9 companies whose vaccine trials are in the third phase.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
